NasdaqCM
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
---|---|---|---|---|---|---|---|---|
CELH | Celsius Holdings | Outperform |
13
|
$73.73 | $68.64 | 29.19% | 5 | $16.04B |
EXAS | Exact Sciences | Buy |
8
|
$58.78 | $90.32 | 50.75% | 7 | $10.81B |
VKTX | Viking Therapeutics | Buy |
5
|
$75.42 | $34.00 | 52.48% | 6 | $8.19B |
WSC | WillScot Mobile Mini Holdings | Buy |
13
|
$39.15 | $53.73 | 35.38% | 7 | $7.38B |
MARA | Marathon Digital Holdings | Hold |
11
|
$18.03 | $12.88 | 41.43% | 1 | $6.91B |
COOP | Mr. Cooper Group | Outperform |
16
|
$79.24 | $75.00 | 17.36% | 5 | $5.10B |
VRRM | Verra Mobility | Outperform |
16
|
$24.35 | $24.50 | 8.83% | 5 | $3.91B |
FRHC | Freedom Holding | - |
10
|
$69.05 | $76.00 | -100.00% | 0 | $3.90B |
CLSK | CleanSpark | Buy |
7
|
$18.12 | $11.87 | 32.45% | 2 | $3.88B |
SPT | Sprout Social | Outperform |
6
|
$52.03 | $63.38 | 38.38% | 9 | $2.88B |
CLDX | Celldex Therapeutics | Buy |
11
|
$37.00 | $63.29 | 108.11% | 1 | $2.45B |
CORT | Corcept Therapeutics | Buy |
16
|
$23.37 | $35.67 | 62.60% | 4 | $2.38B |
RIOT | Riot Platforms | Buy |
9
|
$11.08 | $16.15 | 80.51% | 0 | $2.31B |
TGTX | TG Therapeutics | Outperform |
9
|
$13.32 | $29.44 | 155.26% | 6 | $2.13B |
NEO | NeoGenomics | Outperform |
8
|
$15.22 | $20.09 | 31.41% | 9 | $1.90B |
AMEH | Apollo Medical Holdings | Buy |
14
|
$37.93 | $47.50 | 38.41% | 1 | $1.80B |
CPRX | Catalyst Pharmaceuticals | Buy |
16
|
$15.23 | $26.20 | 70.72% | 2 | $1.79B |
MBIN | Merchants Bancorp | Buy |
12
|
$39.27 | $41.00 | 37.51% | 2 | $1.69B |
VEON | VEON | Buy |
17
|
$23.55 | $40.00 | 69.85% | 0 | $1.68B |
TRCH | Torchlight Energy Resources | - |
6
|
$3.99 | $0.00 | -100.00% | 0 | $1.57B |
NEXT | NextDecade | Outperform |
6
|
$6.65 | $8.50 | 27.82% | 2 | $1.57B |
SGML | Sigma Lithium | Buy |
9
|
$14.96 | $40.00 | 67.11% | 1 | $1.48B |
XPEL | XPEL | Buy |
16
|
$54.41 | $67.00 | 23.14% | 0 | $1.44B |
SYRE | Spyre Therapeutics | Buy |
0
|
$34.89 | $28.17 | 21.81% | 2 | $1.36B |
AHCO | AdaptHealth | Outperform |
14
|
$10.13 | $11.15 | 28.33% | 3 | $1.35B |
UFPT | UFP Technologies | Buy |
16
|
$193.81 | $78.00 | -3.00% | 0 | $1.31B |
ARPO | Aerpio Pharmaceuticals | - |
6
|
$30.30 | $330.00 | 15.51% | 0 | $1.24B |
OSW | OneSpaWorld Holdings | Buy |
6
|
$12.71 | $16.75 | 25.89% | 0 | $1.23B |
IMTX | Immatics N.V. | Buy |
4
|
$9.98 | $19.83 | 100.40% | 5 | $1.18B |
GMHI | Gores Metropoulos | - |
0
|
$0.00 | $16.00 | 0.00% | 0 | $1.15B |
LQDA | Liquidia | Outperform |
6
|
$12.47 | $19.71 | 132.56% | 2 | $1.12B |
TH | Target Hospitality | Outperform |
11
|
$11.31 | $14.00 | 6.10% | 2 | $1.09B |
ESTA | Establishment Labs Holdings | Buy |
7
|
$49.00 | $46.14 | 22.45% | 3 | $1.06B |
MDXG | MiMedx Group | Buy |
6
|
$6.26 | $11.85 | 91.69% | 1 | $954.13M |
ARKO | Arko | Outperform |
14
|
$4.64 | $10.25 | 83.19% | 1 | $933.31M |
KARO | Karooooo | Outperform |
14
|
$29.78 | $525.47 | 1755.98% | 3 | $922.34M |
VRDN | Viridian Therapeutics | Buy |
9
|
$13.60 | $40.21 | 175.74% | 3 | $916.41M |
RPAY | Repay Holdings | Outperform |
12
|
$10.08 | $10.18 | 19.05% | 6 | $874.44M |
SAVA | Cassava Sciences | Outperform |
8
|
$22.30 | $124.00 | 456.05% | 1 | $857.59M |
SLNO | Soleno Therapeutics | Buy |
0
|
$47.32 | $6.00 | 7.78% | 0 | $853.98M |
CIIC | CIIG Merger | - |
1
|
$0.00 | $0.00 | 0.00% | 0 | $838.35M |
GDYN | Grid Dynamics Holdings | Outperform |
8
|
$9.82 | $13.67 | 60.39% | 6 | $787.09M |
CMLF | CM Life Sciences | - |
2
|
$12.48 | $0.00 | -100.00% | 0 | $775.37M |
CYRX | Cryoport | Outperform |
8
|
$16.81 | $17.61 | 7.08% | 3 | $774.61M |
BLFS | BioLife Solutions | Buy |
9
|
$17.86 | $22.57 | 20.38% | 1 | $770.31M |
THRY | Thryv Holdings | Buy |
16
|
$23.40 | $32.75 | 17.52% | 2 | $769.06M |
BFC | Bank First | Hold |
8
|
$77.69 | $100.00 | 10.05% | 1 | $767.89M |
CTIC | CTI BioPharma | - |
6
|
$9.09 | $10.37 | -100.00% | 0 | $762.60M |
GHIV | Gores Holdings IV | - |
0
|
$0.00 | $12.75 | 0.00% | 0 | $697.53M |
IMXI | International Money Express | Outperform |
15
|
$20.98 | $25.25 | 19.16% | 2 | $693.88M |